<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03525847</url>
  </required_header>
  <id_info>
    <org_study_id>10430</org_study_id>
    <nct_id>NCT03525847</nct_id>
  </id_info>
  <brief_title>The Added Value of Contrast Enhancement for Guiding EUS-FNA in Solid Pancreatic Masses</brief_title>
  <official_title>The Added Value of Contrast Enhancement for Guiding EUS-FNA in Solid Pancreatic Masses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Professor Dr. Seicean Andrada</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Iuliu Hatieganu University of Medicine and Pharmacy</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective study designed to show the superiority of contrast guided echoendoscopy versus
      conventional echoendoscopy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective study that compares the results using FNA contrast echoendoscopy versus
      standard FNA echoendoscopy in the diagnosis of solid pancreatic tumors
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Anticipated">January 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic accuracy of CEUS FNA endosonography versus standard FNA endosonography in the etiological cyto histological of pancreatic solid tumors using histology core as comparison between the two methods</measure>
    <time_frame>an average of 2 years</time_frame>
    <description>Diagnostic accuracy of CEUS FNA endosonography versus standard FNA endosonography in the etiological cyto histological of pancreatic solid tumors using histology core as comparison between the two methods</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of histological specimen(histology core) obtained with the two types of FNA biopsies (contrast enhanced and standard)</measure>
    <time_frame>5 days</time_frame>
    <description>Visual analogic scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dysfunction in the two types of biopsies</measure>
    <time_frame>day one</time_frame>
    <description>failure or difficulty reports with each procedure (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison between standand endosonography and contrast enhanced endosonography in obtaining a superior quality in obtaining histology core</measure>
    <time_frame>day one</time_frame>
    <description>Visual analogic scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Endoscopic Ultrasonography</condition>
  <arm_group>
    <arm_group_label>contrast enhanced FNA endosonography</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>First passage in the solid pancreatic tumor using FNA endosonography then with the contrast enhanced FNA endosonography</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FNA standard endosonography</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>First passage in the solid pancreatic tumor using contrast enhanced FNA endosonography then with the FNA endosonography</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Endosonography</intervention_name>
    <description>Puncture of the pancreatic solid mass with fine needle aspiration under endoscopic ultrasonographic control. Passage in the same pancreatic mass of first using standard FNA method then contrast enhanced FNA method or vice versa according to the randomization</description>
    <arm_group_label>contrast enhanced FNA endosonography</arm_group_label>
    <arm_group_label>FNA standard endosonography</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  solid pancreatic tumor lesions

        Exclusion Criteria:

          -  severe coagulopathy of trombocytopenia &lt;50.000

          -  patients refuse for biopsy prelevation or pacient's refuse to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>86 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seicean Andrada</last_name>
    <role>Principal Investigator</role>
    <affiliation>Regional Institute of Gastroenterology and Hepatology &quot;Octavian Fodor&quot;Cluj-Napoca</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Seicean Andrada, Professor</last_name>
    <phone>0040‭(0744) 332 107‬</phone>
    <email>andrada.seicean@umfcluj.ro</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andrada Seicean</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seicean Andrada</name>
      <address>
        <city>Cluj-napoca</city>
        <state>Cluj</state>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seicean Andrada, Professor</last_name>
      <phone>004‭(0744) 332 107‬</phone>
      <email>andrada.seicean@umfcluj.ro</email>
    </contact>
  </location>
  <location_countries>
    <country>Romania</country>
  </location_countries>
  <reference>
    <citation>Hou X, Jin Z, Xu C, Zhang M, Zhu J, Jiang F, Li Z. Contrast-enhanced harmonic endoscopic ultrasound-guided fine-needle aspiration in the diagnosis of solid pancreatic lesions: a retrospective study. PLoS One. 2015 Mar 20;10(3):e0121236. doi: 10.1371/journal.pone.0121236. eCollection 2015.</citation>
    <PMID>25793739</PMID>
  </reference>
  <reference>
    <citation>Yoshinaga S, Suzuki H, Oda I, Saito Y. Role of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for diagnosis of solid pancreatic masses. Dig Endosc. 2011 May;23 Suppl 1:29-33. doi: 10.1111/j.1443-1661.2011.01112.x. Review.</citation>
    <PMID>21535197</PMID>
  </reference>
  <results_reference>
    <citation>Seicean A, Jinga M. Harmonic contrast-enhanced endoscopic ultrasound fine-needle aspiration: Fact or fiction? Endosc Ultrasound. 2017 Jan-Feb;6(1):31-36. doi: 10.4103/2303-9027.196917. Review.</citation>
    <PMID>28218198</PMID>
  </results_reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 16, 2017</study_first_submitted>
  <study_first_submitted_qc>May 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 16, 2018</study_first_posted>
  <last_update_submitted>May 14, 2018</last_update_submitted>
  <last_update_submitted_qc>May 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Iuliu Hatieganu University of Medicine and Pharmacy</investigator_affiliation>
    <investigator_full_name>Professor Dr. Seicean Andrada</investigator_full_name>
    <investigator_title>Principal Investigator Proffesor Dr Phd Md</investigator_title>
  </responsible_party>
  <keyword>Contrast endosonograpy</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>The Study is used to show the superiority of CEUS-FNA endosonography Versus standard FNA endosonography in diagnosis of solid pancreatic masses</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

